Company Search:
Advanced Search
Sponsored Links
Xencor Inc Company Snapshot
Xencor Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xencor Inc with three other companies in this sector in UNITED STATES : Esperion Therapeutics, Inc. (2019 sales of $148.36 million of which 100% was Pharmaceuticals Pro), Tilray Inc ($166.98 million of which 50% was Dried cannabis), and Heron Therapeutics Inc ($145.97 million of which 100% was Polymer Technologies).

Sales Analysis. Sales increased substantially in 2019: Xencor Inc reported sales of $156.70 million for the year ending December of 2019. This represents an increase of 285.9% versus 2018, when the company's sales were $40.60 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Xencor Inc
  Stock Performance Chart for Xencor Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 40.90
(Figures in U.S. Dollars)
1 Week -2.5%   13 Weeks -4.9%  
4 Weeks 21.2%   52 Weeks 16.6%  
Xencor Inc Key Data:
  Ticker: XNCR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 156,700,000
(Year Ending Jan 2020).
Employees: 166
  Currency: U.S. Dollars Market Cap: 2,340,062,948
  Fiscal Yr Ends: December Shares Outstanding: 57,214,253
  Share Type: COMMON Closely Held Shares: 1,165,300
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.